市場調査レポート
商品コード
1415581

アジア太平洋地域の造影剤およびインジェクターシステム市場:分析・予測 (2022-2026年)

Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026

出版日: | 発行: BIS Research | ページ情報: 英文 88 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
アジア太平洋地域の造影剤およびインジェクターシステム市場:分析・予測 (2022-2026年)
出版日: 2024年01月25日
発行: BIS Research
ページ情報: 英文 88 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の造影剤およびインジェクターシステムの市場規模は、2022年の19億8,000万米ドルから、予測期間中は7.24%のCAGRで推移し、2026年には26億2,000万米ドルの規模に成長すると予測されています。

同市場は、造影剤、インジェクターシステム、画像誘導診断の需要増加をもたらす癌や心血管疾患の罹患者数の増加などの要因によって牽引されています。

主要市場統計
予測期間 2022-2026年
2022年評価 19億8,000万米ドル
2026年予測 26億2,000万米ドル
CAGR 7.24%

アジア太平洋地域の造影剤およびインジェクターシステムの市場は、いくつかの重要な要因によって大きな成長を遂げています。第一に、癌や心血管疾患などの発生率の上昇により、造影剤とインジェクターシステムを必要とする画像診断の需要が増加しています。これは特に正確な診断と治療計画に不可欠です。

第二に、医療用画像処理技術の進歩が市場成長をさらに後押ししています。革新的な造影剤とインジェクターシステムの開発により、診断処置の精度と有効性が向上し、ヘルスケアプロバイダーにとってより身近で信頼性の高いものとなっています。

最後に、アジア太平洋地域における医療インフラの拡大と医療費の増加が、市場の拡大に寄与しています。医療施設が画像処理機能の近代化とアップグレードを続けていることから、造影剤とインジェクターシステムの需要はこの地域で上昇基調を続けると予想されています。

当レポートでは、アジア太平洋地域の造影剤およびインジェクターシステムの市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、特許動向、市場規模の推移・予測、主要国別の詳細分析、主要企業の分析などをまとめています。

市場の分類

セグメンテーション1:製品別

  • 造影剤
  • インジェクターシステム

セグメンテーション:インジェクターシステム:製品別

  • インジェクター
  • 消耗品および付属品

セグメンテーション2:国別

  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他

目次

エグゼクティブサマリー

調査範囲

調査手法

第1章 市場

  • 市場の見通し
  • 市場概要
  • 業界の展望
    • 規制および法的要件と枠組み
    • 特許分析
    • 主要動向
  • COVID-19が造影剤およびインジェクターシステム市場に与える影響
  • 市場力学
    • 影響分析
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第2章 地域

  • 概要
  • アジア太平洋
    • 主な調査結果
    • 市場力学
    • 市場規模・予測

第3章 市場:競合ベンチマーキングと企業プロファイル

  • 競合ベンチマーキング
    • 主要な戦略と開発
    • 市場シェア分析
  • 造影剤エコシステムのアクティブ企業
  • 企業プロファイル
    • Beijing Beilu Pharmaceutical Co. Ltd.
    • FUJIFILM Holdings Corporation
    • Jiangsu Hengrui Pharmaceutical Co., Ltd.
    • Jodas Expoim Pvt. Ltd.
    • Shenzen Seacrown Electromechanical Co., Ltd.
    • Sino Medical-Device Technology Co., Ltd.
    • Unijules Life Sciences Ltd.
図表

List of Figures

  • Figure 1: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 3: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
  • Figure 4: Contrast Media Agent and Injector System Market (by Region), $Million, 2021 and 2026
  • Figure 5: Contrast Media Agent and Injector System Market: Research Methodology
  • Figure 6: Primary Research Methodology
  • Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 8: Top-Down Approach (Segment-Wise Analysis)
  • Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
  • Figure 10: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
  • Figure 11: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
  • Figure 12: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 13: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
  • Figure 14: Incidence of Cardiovascular Disease, 2015 - 2019, Million
  • Figure 15: Innovative Vendors Product Solutions
  • Figure 16: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
  • Figure 17: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 18: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 19: Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 20: Asia-Pacific Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 21: China Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 22: China Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 23: China Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 24: Japan Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 25: Japan Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 26: Japan Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 27: India Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 28: India Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 29: India Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 30: Australia Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 31: Australia Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 32: Australia Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 33: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 34: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 35: Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 36: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
  • Figure 37: Regulatory and Legal Activities, January 2018-May 2023
  • Figure 38: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
  • Figure 39: Mergers and Acquisitions, January 2018-May 2023
  • Figure 40: New Offerings, January 2018-May 2023
  • Figure 41: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 42: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 43: Beijing Beilu Pharmaceutical Co. Ltd.: Product Portfolio
  • Figure 44: FUJIFILM Holdings Corporation: Overall Product Portfolio
  • Figure 45: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2020-2022
  • Figure 46: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 47: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2020-2022
  • Figure 48: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 49: Jiangsu Hengrui Pharmaceutical Co., Ltd.: Product Portfolio
  • Figure 50: Jodas Expoim Pvt. Ltd.: Product Portfolio
  • Figure 51: Shenzen Seacrown Electromechanical Co., Ltd.: Product Portfolio
  • Figure 52: Sino Medical-Device Technology Co., Ltd.: Product Portfolio
  • Figure 53: Unijules Life Sciences Ltd.: Product Portfolio

List of Tables

  • Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
  • Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
  • Table 5: Some of the Contrast Media Reactions and Effects
  • Table 6: Guidelines for Contrast Administration and Hydration
  • Table 7: Asia-Pacific Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 8: Contrast Media Ecosystem Active Players
目次
Product Code: BHR1815SS

“The Asia-Pacific Contrast Media Agent and Injector System Market Expected to Reach $2.62 Billion by 2026.”

Introduction to Asia-Pacific Contrast Media Agent and Injector System Market

The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

KEY MARKET STATISTICS
Forecast Period2022 - 2026
2022 Evaluation$1.98 Billion
2026 Forecast$2.62 Billion
CAGR7.24%

Market Introduction

The APAC Contrast Media Agent and Injector System Market is witnessing substantial growth driven by several key factors. Firstly, the rising incidence of medical conditions such as cancer and cardiovascular diseases has led to an increased demand for imaging procedures that require contrast media agents and injector systems. This is particularly crucial for accurate diagnosis and treatment planning.

Secondly, advancements in medical imaging technologies have further fueled market growth. The development of innovative contrast media agents and injector systems has improved the precision and effectiveness of diagnostic procedures, making them more accessible and reliable for healthcare providers.

Lastly, the expanding healthcare infrastructure and increasing healthcare expenditure in the Asia-Pacific region have contributed to the market's expansion. As healthcare facilities continue to modernize and upgrade their imaging capabilities, the demand for contrast media agents and injector systems is expected to continue its upward trajectory in the region.

Market Segmentation:

Segmentation 1: by Product

  • Contrast Media Agents
  • Injector Systems

Segmentation: Injector Systems (by Product)

  • Injector
  • Consumables and Accessories

Segmentation 2: by Country

  • China
  • Japan
  • India
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The APAC contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled

  • Beijing Beilu Pharmaceutical Co. Ltd.
  • FUJIFILM Holdings Corporation
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Shenzen Seacrown Electromechanical Co., Ltd.
  • Sino Medical-Device Technology Co., Ltd.
  • Unijules Life Sciences Ltd.

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Markets

  • 1.1. Market Outlook
    • 1.1.1. Product Definition
    • 1.1.2. Inclusion and Exclusion Criteria
  • 1.2. Market Overview
  • 1.3. Industry Outlook
    • 1.3.1. Regulatory and Legal Requirements and Framework
      • 1.3.1.1. Regulatory and Legal Requirements and Framework in Asia-Pacific
        • 1.3.1.1.1. China
        • 1.3.1.1.2. Japan
    • 1.3.2. Patent Analysis
      • 1.3.2.1. Patent Filing Trend (by Year)
      • 1.3.2.2. Patent Filing Trend (by Country)
    • 1.3.3. Key Trends
      • 1.3.3.1. Nanoparticle-Based Contrast Agents
      • 1.3.3.2. Development of Safer Contrast Media Agent
      • 1.3.3.3. Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
  • 1.4. Impact of COVID-19 on Contrast Media Agent and Injector System Market
    • 1.4.1. Pre-COVID-19 Impact
    • 1.4.2. During COVID-19 Impact
    • 1.4.3. Post-COVID-19 Impact
  • 1.5. Market Dynamics
    • 1.5.1. Impact Analysis
    • 1.5.2. Market Drivers
      • 1.5.2.1. Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
      • 1.5.2.2. Upsurge in Demand for Image-Guided Diagnostics
      • 1.5.2.3. Growing Number of Regulatory Approvals
    • 1.5.3. Market Restraints
      • 1.5.3.1. Rising Health Concerns Post Usage of Contrast Media Agents in Body
    • 1.5.4. Market Opportunities
      • 1.5.4.1. IT Advances in Contrast Media Injectors

2. Region

  • 2.1. Overview
  • 2.2. Asia-Pacific
    • 2.2.1. Key Findings
    • 2.2.2. Market Dynamics
      • 2.2.2.1. Impact Analysis
    • 2.2.3. Market Size and Forecast
      • 2.2.3.1. Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.1.1. Asia-Pacific Contrast Media Injector System Market (by Product)
      • 2.2.3.2. Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
        • 2.2.3.2.1. China
          • 2.2.3.2.1.1. Market Sizing and Forecast
          • 2.2.3.2.1.1.1. China Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.1.1.1.1. China Contrast Media Injector System Market (by Product)
        • 2.2.3.2.2. Japan
          • 2.2.3.2.2.1. Market Sizing and Forecast
          • 2.2.3.2.2.1.1. Japan Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.2.1.1.1. Japan Contrast Media Injector System Market (by Product)
        • 2.2.3.2.3. India
          • 2.2.3.2.3.1. Market Sizing and Forecast
          • 2.2.3.2.3.1.1. India Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.3.1.1.1. India Contrast Media Injector System Market (by Product)
        • 2.2.3.2.4. Australia
          • 2.2.3.2.4.1. Market Sizing and Forecast
          • 2.2.3.2.4.1.1. Australia Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.4.1.1.1. Australia Contrast Media Injector System Market (by Product)
        • 2.2.3.2.5. Rest-of-Asia-Pacific
          • 2.2.3.2.5.1. Market Sizing and Forecast
          • 2.2.3.2.5.1.1. Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.5.1.1.1. Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)

3. Markets - Competitive Benchmarking & Company Profiles

  • 3.1. Competitive Benchmarking
    • 3.1.1. Key Strategies and Development
      • 3.1.1.1. Regulatory and Legal Activities
      • 3.1.1.2. Partnerships, Collaborations, and Business Expansions
      • 3.1.1.3. Mergers and Acquisitions
      • 3.1.1.4. New Offerings
    • 3.1.2. Market Share Analysis
      • 3.1.2.1. Market Share Analysis, by Contrast Media Agent Market
      • 3.1.2.2. Market Share Analysis, by Contrast Media Injector System Market
  • 3.2. Contrast Media Ecosystem Active Players
  • 3.3. Company Profiles
    • 3.3.1. Beijing Beilu Pharmaceutical Co. Ltd.
      • 3.3.1.1. Company Overview
      • 3.3.1.2. Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.1.3. Recent Developments
      • 3.3.1.4. Analyst Perception
    • 3.3.2. FUJIFILM Holdings Corporation
      • 3.3.2.1. Company Overview
      • 3.3.2.2. Role of FUJIFILM Holdings Corporation in the Contrast Media Agent and Injector System Market
      • 3.3.2.3. Financials
      • 3.3.2.4. Analyst Perception
    • 3.3.3. Jiangsu Hengrui Pharmaceutical Co., Ltd.
      • 3.3.3.1. Company Overview
      • 3.3.3.2. Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.3.3. Recent Developments
      • 3.3.3.4. Analyst Perception
    • 3.3.4. Jodas Expoim Pvt. Ltd.
      • 3.3.4.1. Company Overview
      • 3.3.4.2. Role of Jodas Expoim Pvt. Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.4.3. Analyst Perception
    • 3.3.5. Shenzen Seacrown Electromechanical Co., Ltd.
      • 3.3.5.1. Company Overview
      • 3.3.5.2. Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.5.3. Recent Developments
      • 3.3.5.4. Analyst Perception
    • 3.3.6. Sino Medical-Device Technology Co., Ltd.
      • 3.3.6.1. Company Overview
      • 3.3.6.2. Role of Sino Medical-Device Technology Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.6.3. Analyst Perception
    • 3.3.7. Unijules Life Sciences Ltd.
      • 3.3.7.1. Company Overview
      • 3.3.7.2. Role of Unijules Life Sciences Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.7.3. Analyst Perception